chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Trauma, Fall   Source of Information:  Patient   Mechanism of Injury/Details of Event:  This is a 59y.o. female who presents after falling on ice with severe LLE pain. She denies LOC. She denies any other injuries. Hx of tobacco abuse. No thinners. No significant medical hx.
patient fainted after receiving his vaccine. we were able to get him onto the floor before he fell out of the chair. we gave him an ice pack and some water when he came to, he quickly regained his color and was feeling much better after the 15 minute wait time.
pt recv vax AUG96 & baseline liver function test were taken 2 days prior to vax in preparation for methotrexate therapy (for arthritis) 5 days p/vax ALT was elevated 3 fold;methotrexate was discontinued;subsequent showed cont ALT elevation;
Shingles - started with chills and stomach distress on March 11, minor rash on and pain in back, worse rash on March 20, diagnosed on March 21. Took about a month or more to clear.
Hives , rash ,  open wound where rash and hives were present on the left anticubital area on the same arm the vaccine was administered
Non-Responder to 9 Doses of a Previous Hepatitis B Vaccine Responded to Heplisav Series; Initial Report Received on 08-Nov-2021  In a case series patients with documentation of 6 doses of a standard hepatitis B vaccine, received 2 doses of Heplisav-B, and the results of post-vaccination tests were collected from existing health records within the health system.    Patient received an initial hepatitis B series at 21-years-old and a second hepatitis B series at 22-years-old.   A total of 9 doses of the standard hepatitis B vaccine were administered.  The patient was considered a non-responder.  At 33-years-old, the patient received the initial dose of Heplisav-B.   The patient completed the Heplisav-B series (details not specified).  On an unspecified date, at least 1 month after completing the Heplisav-B series, the hepatitis B surface antibody was positive.  No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
This spontaneous report as received from a physician refers to a 66 year old female patient. On an unspecified day in July 2013 the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot# not reported). The patient developed a vesicular "spot" on her left ear a few days after receiving ZOSTAVAX. The "spot" cleared however the patient eventually developed a diffused rash on her face in September 2013 on an unspecified day. The patient was prescribed prednisone, unspecified dose, on an unspecified date for the rash. Physician described the rash as a confluent rash that covers the patient's whole face except around her eyes. Physician stated that an IgG assay for IgG-class antibodies to varicella zoster virus was tested on an unspecified date, with positive results, another IgG test was done and the results did not differ from the first IgG test results. IgM testing was also completed with a negative result on an unspecified date. The prednisone was discontinued as the patient was starting to show signs of ADDISON's Disease on an unspecified date. The patient still had a very red rash on her entire face that was not going away. The patient sought unspecified medical attention. Additional information has been requested.
Injection inadvertently given subcutaneously (should have been an intramuscular shot)
Patient had swelling of the upper lip that began the morning 11/6/21.  Patient states that she has had issues with allergic reactions mostly to molds in the past and takes allegra daily. This morning she awoke with left upper outer lip swelling. She took her allegra and feels that the swelling improved but just "spread out" over her upper lip.   No tongue swelling, drooling, difficulty swallowing, dyspnea, nausea, vomiting, diarrhea, fever. No other symptoms. No known exposures.   Benadryl administered. On re-evaluation patient's lip swelling significantly improved. No new symptoms. Return criteria reviewed. All questions answered. Patient discharged in stable condition.
pain in my arms; swelling in my joints; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in May2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation.  Medical history included fibromyalgia and Lyme disease; from unknown dates and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 in Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunization and patient experienced severe pain in shoulders and could not raise hands above elbows. On an unspecified dates in May2021, after the second dose, the patient experienced excruciating pain in arms and swelling in joints. It was also reported that patient still had the symptoms of the first dose. The patient reported it had been 3 and 1/2 months and was getting no relief, was getting desperate and needed help. The outcome of the events was not recovered.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.
Redness and swelling of arm extending from injection site down to elbow.  Itching and aching at site.
Developed GBS,  loss of mobility. Eventually paralyzed. Intubated for a week. Been hospitalized for over a month.  Now in
Known history of ASCVD. The patient was admitted  for further evaluation and treatment of acute STEMI associated with symptoms of chest pain and shortness of breath with exertion. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Mild soreness at injection site; colorful flashing light in the peripheral vision of my right eye; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  colorful flashing light in the peripheral vision of my right eye/photopsia, mild soreness at injection site/vaccination site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 17 Feb 2021, the patient experienced colorful flashing light in the peripheral vision of my right eye/photopsia. On 18 Feb 2021, the patient experienced mild soreness at injection site/vaccination site pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   on an unknown date the outcome of mild soreness at injection site/vaccination site pain was unknown.
This case was reported by a healthcare professional (nurse) via a sales representative and described the occurrence of injection site soreness in a 33-year-old male subject who was vaccinated with FLUARIX TETRA (GlaxoSmithKline). On 25 October 2013 the subject received a dose of FLUARIX TETRA (unknown, right arm). On 25 October 2013, less than one day after vaccination with FLUARIX TETRA, the subject experienced injection site soreness. The subject was vaccinated in the right arm with FLUARIX TETRA and experienced soreness in right arm. It was unknown if the soreness in the right arm was a local injection site reaction or systemic reaction. It was unknown if medical attention was required. At the time of reporting the outcome of the or injection site soreness was unspecified. Follow-up information was received on 09 December 2013 via healthcare professional who reported the subject received 0.5ml of FLUARIX TETRA intramuscularly on 25 October 2013. The reporter did not consider the event to be serious. No action was taken with FLUARIX TETRA. The outcome of the injection site soreness that the subject experienced was unknown.
PATIENT WAS BEING MONITORED POST COVID VACCINE. INFORMED STAFF THAT HER ARM FELT A LITTLE TINGLING, AND SOME HEAVINESS. PATIENT HAD NO PROBLEMS WITH MOVEMENT OR PAIN, NO OTHER COMPLICATIONS JUST TINGLING AND SOME HEAVINESS. CLINICAL SPECIALIST  WAS INFORMED, AND PATIENT WAS FURTHER MONITORED. UPON FURTHER MONITORING PATIENT DID NOT GET WORSE, NO FURTHER SYMPTOMS AT THAT TIME. PATIENT WAS INFORMED TO FOLLOW UP WITH PHYSICIAN IF ANY CHANGES OCCURED POST MONITORING.
Broke out with rash this AM. New drugs a right arm, rash generalized on all, slight itchy.
Hypertension: systolic pressure above 200 at pharmacy, taken to emergency department and physician determined the hypertension to be anxiety related.
pt received flu vaccine on 2/23/05. after that time experienced swelling and pain and decreased range of motion in right shoulder. presented on 3/4/05 with a frozen right shoulder. was referred to the emergency department. Since that time patient has regained full range of motion in shoulder and trend of improvement of his symptoms.
Swollen hot red itching injection site; Soreness, Fever, Aches, Headache, Fatigue, Triggered some mild asthmatic symptoms. Took over the counter medication, and rested. Attempted to call doctor's office this morning at 9am but there was no answer and sent fax to let them know.
Pain, redness, and swelling in right arm from about 6 inches above elbow to 6 inches below elbow
Lymph nodes in left arm pit slightly swollen; Lymph nodes in left arm pit slightly swollen and sore; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 28Feb2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 07Feb2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 02Mar2021, the patient experienced that the lymph nodes in left arm pit were slightly swollen and sore. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lymph nodes in left arm pit slightly swollen and sore was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
4 days after vaccine, swollen lymph nodes noted on the left side of neck and under left arm to the point my left hand was numb and painful.  On day 6 tingling and numbness was noted across my face and in my arms and legs.  The arm pain subsided after about a week but I am almost 6 weeks out any the tingling is still present.
Patient developed fever that would not break.  Then began jerking pdy motions and acting as if he could not move his arm.  Inconsolible crying.  Took to the emergency room.  By the time the doctor came back there fever had broke and seemed ok.  They gave him Benadryl.  Patient developed chicken pox a week or so later from the vaccine.  Patient began to regress and within a couple months had completely regressed.  Lost words, skills, social skills and awareness of surroundings.  Went from social happy advanced child to non verbal and in his own world.  Did not even notice rain.  Was diagnosed with autism in September of 2006.  Before the vaccines, no development concerns.  Crawled at 4 mnths, said first word at 6 mnths, walked at 8 mnths.  Extremely social and happy.  8/18/08 Developmental eval dated 9/14/2006 received with DX:  Pervasive Developmental Disorder (Autism). Pt refered for developmental concerns, language delay and social interaction concerns. Parent reported normal growth, interaction and development until about 1 yr of age. Initially had a few word vocab, but stopped using them ~15 months. Currently shows significant delays in all domains of development, including cognitive development
-MMR, Varicella given, one in either thigh. About 15 minutes later site noted to have redness, also 2-3 hives on each site. Given Benadryl 3/4 tsp advised mom to motion site at home. Call clinic if further swelling.
No additional adverse events reported; Agent informed Pharmacist of dosage information as listed in prescribing information, that dosage is listed as 0.5 mL and 1.0 mL and clarify if patient received "5 mcg" and Pharmacist confirms dose.; adult patient was administered pediatric dose; This spontaneous report was received from a pharmacist concerning an adult female patient of unknown age. No concurrent condition, medical history, or concomitant therapy was reported.    On 20-JUL-2021, the patient was prescribed and vaccinated with pediatric dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) (strength and route were unknown; lot # T024551 has been verified to be a valid lot number, expiration date reported and confirm upon internal validation as 03-NOV-2022; thimerosal free), 5 Micrograms for prophylaxis (incorrect dose administered). It was her first dose.   The pharmacist was informed of dosage information as listed in prescribing information, that dosage was listed as 0.5 mL and 1.0 mL (product prescribing issue) and clarified if the patient received "5 mcg". The pharmacist confirmed dose. No additional adverse events were reported.
pain, redness, induration rt upper arm w/t104; tx w/Keflex 250mg 200ml, warm compress, Motrin/APAP;
04/10/21, Getting 2nd shot around 1:30pm on left arem The vicinne needle was injected into left arm. in seconds, the water came down the arm(thinking it'svicinne from needle), nurse got tissue and wiped.I asked nurse if it's a good shot, she said yes and give me the instruction for pain/tylonal/ice pack etc.. I went home and expected getting some reaction( light or serious). by 04/11, 12am, no reaction. I am very concerned if  I received enough dosage to to create affective antibodies. Please advise how could i a test of volumn of antiboy? I need to know to have a piece of mind. I have two wedding comming and pay repect to my father who passed away
Had mine today!! ... My arm is really sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2021-2022 season) for prophylaxis.   On 6th November 2021, the patient received the 1st dose of Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season. On 6th November 2021, less than a day after receiving Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine and Influenza vaccine Quadrivalent 2021-2022 season.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received shingles shot on the day of reporting along with the flu shot on the other arm. The patient's arm was really sore. The patient went to the pharmacy and nobody said anything about a second shot. And hence wanted to go and look at the paper work they gave him/ her.
Guillen-Barre Syndrome. AIDP ongoing CIPD.  3 Week Hospitalization, ongoing PT and IVIG
Pt to ED 1/22 for hypotension, respiratory distress and AFib, upon arrival pt is not alert to any stimuli. COVID+ 1/22, on Vancomycin. Pt coded twice, first time for 5 minutes second for 1 minute, pt received antibiotics and multiple boluses. Family changed code status to comfort care, pt expired 1/22.
Fever, trembling, stomach ache, nausea, severe body ache, loss of appetite.
In mid-October, I had continuously a low-grade headache and a lot of eyelid twitch and that is very frequent, several times a day. I made an appointment with a Neurologist 12/30/2021 07:30AM to see what is going on with my eyes.
Shortly after 1st Moderna shot on Mar 2 2021 I had what I thought was an asthma exacerbation. When breathing did not improve with previously prescribed rescue inhaler and daily oral medication, I saw my primary on Mar 26, 2021.  My primary gave me a  nebulizer treatment, prescribed a z-pack and renewed my Albuteral rescue inhaler. I got no relief from those interventions. On Mar 30, 2021 I had my 2nd Moderna vaccination. I walk daily, usually fast paced with moderate-high exertion, but while having difficulty breathing I  walked slowly with light exertion. On Apr 2nd I was on my walk, short of breath, when I experienced pain in my left chest which moved into my left arm. My left arm was tingling then numb. I stopped and rested until the pain went away, maybe 3-4 minutes. I continued walking  back to the car. My arm remained tingling and numb during that time and for about 30 minutes.  I never felt the same level of pain that I did on April 2nd, but I continued to have shortness of breath, felt twinges/pinches and sometime a quick stab in my left chest. I also had some tightness/pressure in my left neck/throat. My blood pressure was also higher than normal for me. I have had a couple of asthma attacks in my life, but my asthma has been well-controlled and any breathing issues were always able to be resolved with my acute inhaler and a Nebulizer treatment. I had never had chest pain. I saw my primary at a first available appointment who set me up with appointments for pulmonary and cardiology. During this period I also was prescribed additional medications; 1 baby aspirin/day; Symbicort; Metoprolol; nitro (if needed for chest pain). My breathing got worse with the Metoproplol after 5 days and I was given Amlodipine instead. My breathing got easier with the change in medication. I found that lying down on my side helped my breathing. I have not been wakened by not being able to breathe during sleep and feel good first thing in the morning. Once I start moving around in the morning I feel shortness of breath during normal activity. Some days are  improved, some days aren't as good. I have been avoiding even moderate exertion so I don't know if I would have chest pain like I experienced on Apr 2nd again. In addition to the shortness of breath I still feel a twinge/pinch in my left chest and a tightness/pressure on my left neck/throat area. My cardio cath Left/Right was performed Jun 14, 2021. There was no sign of any issues with my heart and no sign of pulmonary hypertension. As of this submission on  Jun 15, 2021, I am grateful that there are no problems or concerns with my heart or lungs. I'll follow my doctor's orders to increase exercise and will have a Pulmonary Function Test in July. I was a person who went from being able to walk 3 miles at a fast pace with 100 foot elevation changes within 1/4 mile to having difficulty walking from my kitchen to the bathroom in a matter of weeks. The only anomaly in that time frame was my 2 Moderna vaccine shots. I'm submitting this because I feel you should know and because I am concerned with what I should do if a booster is required in the future.
red circle the size of a "half dollar"; it itches like crazy; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy). At the time of the report, VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Started with general malaise on 3/27.  Then starting feeling worse and reported to aunt on 3/30 complaining of stiff neck, difficulty sleeping, bumps noted on head, jaw pain and blisters and hives in hair.
Mother states site of MMRV on left arm swelled to size of an egg w/ onset 24h after administration.  Child's knees were itchy, areas around his ears were red, and he had a fever of 100-101.2 x 2days.  Mother took child to doctor she works with; mother gave Benadryl and applied ice x 3d.  Mother also states site where DTaP given was red x 3-4d w/ onset 2d after vaccine administration.
CO complained of ?tingling? sensation in tongue about 20 minutes into observation period. A provider was notified, vitals taken, provider assessed patient, 50 mg Benadryl was given orally at 11:29am, vitals were taken every 15 minutes and directly observed until 12:05pm when patient said her tongue was feeling better. Provider reassessed CO and let CO go home at 12:05pm.
patient felt tired, sore arm, dizzy and headache; sore arm; dizzy; headache; This is a spontaneous report from a contactable consumer. A 12-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 06Jun2021(at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 16May2021(at the age of 12-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Jun2021 at 09:00, the patient experienced felt tired, sore arm, dizzy and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if patient received any treatment for the events. The clinical outcome of the events felt tired, sore arm, dizzy and headache was recovered on unknown date in 2021.  information on lot/batch number has been requested
About 20 minutes after my first dose of COVID-19 Moderna, my eyes became very red and itchy. Then my entire body. My tongue started to feel enlarged and my heart was racing. I went to the ER and where they administered steroids and Benadryl. The symptoms became better but still had the mild symptoms of itchy and weird tongue that lasted for two weeks.
Patient returned to school after vaccines given. School contacted mom and she had a friend pick him up. Reports stiff all over, hear racing with some difficulty breathing and walking. Mom gave him 2 ALEVE and he rested, when he awoke he was fine.
Congestion, fatigue, weakness, COVID pneumonia. Hospitalized 04/07/203.